Abstract 2184: Defining cancer initiating cells and their vulnerabilities in renal cell carcinoma.
Zohreh Mehrjoo(McGill Genome Centre), Y. Riazalhosseini(McGill Genome Centre), Sahin Özgür(MUSC Hollings Cancer Center), Kevin Petrecca(McGill University Health Centre), Simon Tanguay(McGill University Health Centre), Hamed S. Najafabadi(University of Toronto), Matthew G. Annis(McGill University Health Centre), Özge Saatci(Medical University of South Carolina), Ali Shahini(Mashhad University of Medical Sciences), Jonathan Spicer(Chinese Academy of Medical Sciences & Peking Union Medical College), Larisa M. Soto(McGill Genome Centre), Tamiko Nishimura(University of Alberta), Peter M. Siegel(L'Oréal (France)), Matthew Dankner(McGill University), Morag Park(McGill University Health Centre), Hong Zhao(McGill University), Tianyuan Lu(McGill Genome Centre), D. Zuo(McGill University), Hellen Kuasne(McGill University), Virginie Pilon(McGill University Health Centre), Anne-Marie N. Fortier(McGill University), Ariel Madrigal Aguirre(McGill Genome Centre)
Cited by 0
Related Papers
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k
Intraoperative brain cancer detection with Raman spectroscopy in humans
|Science Translational Medicine|2015|625
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
|Nature Communications|2020|601
MAFG-driven astrocytes promote CNS inflammation
|Nature|2020|510